An automated tumor marker analyzer measures biomarkers like PSA, CEA, AFP, CA-125, and CA-19-9 in blood samples. It uses immunoassay technology to provide high-sensitivity and high-specificity results. Typically installed in clinical biochemistry or oncology-focused pathology labs. It supports diagnosis, monitoring of treatment effectiveness, and early detection of cancer recurrence. The analyzer offers fast turnaround times essential for oncology decision-making. Automated reagent handling reduces manual errors. Many models include LIS connectivity for seamless data transfer. Ideal for medium to high-workload laboratories in cancer centers. Supports NABL-accredited testing standards in India. Ensures reproducible, laboratory-grade diagnostic performance.